We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Procter & Gamble (PG) in Q4 Earnings?
Read MoreHide Full Article
The Procter & Gamble Company (PG - Free Report) is set to report fourth-quarter fiscal 2017 results on Jul 27, before the market opens. Last quarter, it delivered a positive earnings surprise of 2.13%.
In fact, despite sales remaining subdued, the consumer goods company delivered a positive earnings surprise in each of the trailing four quarters, the average being 3.97%.
Let’s see how things are shaping up for this announcement.
Factors to Consider
Procter & Gamble has been struggling for the last few years to boost sales. Notably, the company’s sales declined in the last 13 consecutive quarters. Major foreign exchange headwind, weak volumes, divestitures and slowing market growth have been hurting the company’s sales. Soft consumer-spending environment in developed markets also adds to the worries.
The trend is not likely to change for the to-be-reported quarter. Softness in the U.S. and volatility in developing markets will likely have an adverse impact on Procter & Gamble’s results. In fact, categories in the company’s largest and profitable market, the U.S. (accounting for 40% of net sales), grew by less than a point in the fiscal third quarter, a lot lower than the roughly 2% growth registered in the first half of fiscal 2017. Overall, the company posted flat organic sales growth in developed markets.
Meanwhile, Procter & Gamble has been taking various restructuring initiatives aimed at generating higher profit and lowering costs. These initiatives have helped the company to accelerate margins growth amid the slowdown in sales. However, fiscal third quarter’s gross as well as operating margins fell despite benefitting from productivity savings. This was due to higher input costs, a planned increase in marketing spending, higher R&D costs, and lower pricing due to increased competition.
Hence, lower sales accompanied by higher commodity costs, more investments for marketing and increased R&D spending to push demand might adversely affect margins, thereby putting pressure on bottom line in the to-be-reported quarter. This will be partly offset by cost-saving measures.
For the fiscal fourth quarter, the Zacks Consensus Estimate for earnings is pegged at 78 cents, reflecting a decrease of 0.8% year over year. Meanwhile, the consensus estimate for revenues is pegged at $15.98 billion, implying a 0.8% decline.
Earnings Whispers
Our proven model does not conclusively show that Procter & Gamble is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. However, that is not the case here as you will see below.
Zacks ESP: Procter & Gamble’s Earnings ESP is 0.00% as the Most Accurate estimate and the Zacks Consensus Estimate are pegged at 78 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Procter & Gamble’s Zacks Rank #3 increases the predictive power of ESP. However, we also need to have a positive ESP to be confident about an earnings surprise.
Note that we caution against stocks with a Zacks Rank #4 or 5 (Sell rated) going into an earnings announcement, especially when the company is witnessing negative estimate revisions.
Procter & Gamble Company (The) Price and EPS Surprise
It is slated to release quarterly results on Aug 3.
Tyson Foods, Inc. (TSN - Free Report) has an Earnings ESP of +1.64% and a Zacks Rank #2. Tyson is slated to release quarterly results on Aug 7.
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
What's in Store for Procter & Gamble (PG) in Q4 Earnings?
The Procter & Gamble Company (PG - Free Report) is set to report fourth-quarter fiscal 2017 results on Jul 27, before the market opens. Last quarter, it delivered a positive earnings surprise of 2.13%.
In fact, despite sales remaining subdued, the consumer goods company delivered a positive earnings surprise in each of the trailing four quarters, the average being 3.97%.
Let’s see how things are shaping up for this announcement.
Factors to Consider
Procter & Gamble has been struggling for the last few years to boost sales. Notably, the company’s sales declined in the last 13 consecutive quarters. Major foreign exchange headwind, weak volumes, divestitures and slowing market growth have been hurting the company’s sales. Soft consumer-spending environment in developed markets also adds to the worries.
The trend is not likely to change for the to-be-reported quarter. Softness in the U.S. and volatility in developing markets will likely have an adverse impact on Procter & Gamble’s results. In fact, categories in the company’s largest and profitable market, the U.S. (accounting for 40% of net sales), grew by less than a point in the fiscal third quarter, a lot lower than the roughly 2% growth registered in the first half of fiscal 2017. Overall, the company posted flat organic sales growth in developed markets.
Meanwhile, Procter & Gamble has been taking various restructuring initiatives aimed at generating higher profit and lowering costs. These initiatives have helped the company to accelerate margins growth amid the slowdown in sales. However, fiscal third quarter’s gross as well as operating margins fell despite benefitting from productivity savings. This was due to higher input costs, a planned increase in marketing spending, higher R&D costs, and lower pricing due to increased competition.
Hence, lower sales accompanied by higher commodity costs, more investments for marketing and increased R&D spending to push demand might adversely affect margins, thereby putting pressure on bottom line in the to-be-reported quarter. This will be partly offset by cost-saving measures.
For the fiscal fourth quarter, the Zacks Consensus Estimate for earnings is pegged at 78 cents, reflecting a decrease of 0.8% year over year. Meanwhile, the consensus estimate for revenues is pegged at $15.98 billion, implying a 0.8% decline.
Earnings Whispers
Our proven model does not conclusively show that Procter & Gamble is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. However, that is not the case here as you will see below.
Zacks ESP: Procter & Gamble’s Earnings ESP is 0.00% as the Most Accurate estimate and the Zacks Consensus Estimate are pegged at 78 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Procter & Gamble’s Zacks Rank #3 increases the predictive power of ESP. However, we also need to have a positive ESP to be confident about an earnings surprise.
Note that we caution against stocks with a Zacks Rank #4 or 5 (Sell rated) going into an earnings announcement, especially when the company is witnessing negative estimate revisions.
Procter & Gamble Company (The) Price and EPS Surprise
Procter & Gamble Company (The) Price and EPS Surprise | Procter & Gamble Company (The) Quote
Stocks to Consider
Here are a few consumer staples companies that, according to our model, have the right combination of elements to post an earnings beat this quarter:
Dr Pepper Snapple Group, Inc has an Earnings ESP of +2.36% and a Zacks Rank #3. The company is slated to release quarterly results on Jul 27.
Church & Dwight Company, Inc. (CHD - Free Report) has an Earnings ESP of +2.56% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
It is slated to release quarterly results on Aug 3.
Tyson Foods, Inc. (TSN - Free Report) has an Earnings ESP of +1.64% and a Zacks Rank #2. Tyson is slated to release quarterly results on Aug 7.
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>